SETBP1 and atypical chronic myeloid leukemia, BCR-ABL1 negative: In [42] Piazza et al. used high-throughput exome sequencing technology to identity somatically acquired mutations in 64 ACML patients, and found a previously unidentified recurring missense point mutation hitting SETBP1.